Clinical Trial Update: Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating biomarkers in patients with resectable oral cavity cancer who receive preoperative treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Oral Cavity Cancer | Phase 1, Phase 2 | Status: COMPLETED